Onco-sexology support for people newly diagnosed with cancer
Impact of Onco-sexology Support on the Quality of Life of Patients Newly Diagnosed for Cancer
NA · Hôpital Européen Marseille · NCT06332573
This project will try onco-sexology support with adults newly diagnosed with cancer to see if it improves their quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 168 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hôpital Européen Marseille (other) |
| Locations | 1 site (Marseille) |
| Trial ID | NCT06332573 on ClinicalTrials.gov |
What this trial studies
Adults newly diagnosed with cancer at Hôpital Européen Marseille are offered structured onco-sexology support integrated into their oncology care. The intervention consists of scheduled consultations with trained onco-sexologists addressing sexual health, intimacy, and related counseling alongside standard cancer treatments. Patient-reported outcomes such as overall quality of life and sexual function will be collected over time using validated questionnaires and compared with usual care. The trial includes both curative and palliative patients who provide informed written consent.
Who should consider this trial
Good fit: Adults (≥18) newly diagnosed with any cancer, including those receiving palliative care, who can give informed written consent and attend consultations at the Marseille site.
Not a fit: Pregnant or breastfeeding people, individuals deprived of liberty, those under legal protection, or anyone unable to give informed consent are excluded and will not participate or receive benefit from this program.
Why it matters
Potential benefit: If successful, onco-sexology support could improve intimate relationships and overall quality of life for people during and after cancer treatment.
How similar studies have performed: Some smaller programs and pilot studies of sexual health counseling in oncology report improvements in sexual function and quality of life, but randomized evidence is limited and the approach remains underused.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥ 18 years * Newly cancer diagnosis, including palliative care * Having given free and informed written consent Exclusion Criteria: * Pregnant or breastfeeding woman * Persons deprived of their liberty by a judicial or administrative decision. * Persons who are subject to a legal protection measure or who are unable to express their consent.
Where this trial is running
Marseille
- Hôpital Européen Marseille — Marseille, France (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer